Sudden or rapidly worsening vision while taking semaglutide is an emergency. Go immediately to an emergency department or eye-casualty service for specialist ophthalmologic assessment, even if the change is painless, affects only part of one eye, or improves. Semaglutide has been classified by European regulators as associated with the very rare eye condition non-arteritic anterior ischemic optic neuropathy (NAION), but a causal relationship has not been proven. Do not stop or continue treatment on your own: if NAION is confirmed, regulators advise stopping semaglutide, while eye and prescribing specialists should make the final medication decision together.
What NAION is and why sudden vision loss matters
Non-arteritic anterior ischemic optic neuropathy (NAION) is a problem with blood flow to the front portion of the optic nerve, the structure that carries visual information from the eye to the brain. “Non-arteritic” means the problem is not caused by inflammation of the blood vessels. It is sometimes called an “eye stroke,” although that phrase can be confusing: NAION affects the optic nerve rather than the brain.
As an Amazon Associate I earn from qualifying purchases.
The typical presentation is abrupt, painless loss or blurring of vision in one eye, often noticed on waking. The change may be a general cloudiness, a missing area in the upper or lower field of vision, or a substantial drop in sharpness. Partial loss still counts as an emergency. An examination may show swelling of the optic disc, where the optic nerve enters the eye.
Vision lost from NAION is often permanent. The World Health Organization has reported that no effective treatment has been identified that restores visual acuity once NAION occurs. That is why the priority is rapid examination and diagnosis, not trying to treat the problem at home.
#1 Best Overall
- [Ultra-Lightweight Ear Buds Designed for Small Ears] Each earbud weighs only 3.7g and features a compact, ergonomic in-ear design made especially for small ears. Secure, low-profile, and comfortable for workouts, all-day wear or overnight sleeping.The ultra-slim profile sits flush in your ear with no hard edges poking or rubbing, so you can even sleep on your side without discomfort.
- [Immersive Stereo Sound with TOZO OrigX Technology] TOZO OrigX tuning delivers clear vocals, balanced mids, and natural stereo sound for music, podcasts, and videos.
- [Long Battery Life for Daily Use] Get up to 7 hours of playtime on a single charge, with up to 32 hours total using the charging case—ideal for workdays, commuting, and extended listening sessions.
- [Bluetooth 5.3 & Stable Connection] Bluetooth 5.3 provides fast pairing, stable wireless performance, and reduced dropouts as you move around home or office.
- [Deep Bass with Clear Vocals] High-performance drivers produce punchy bass while keeping vocals clean and detailed for everyday listening.
What regulators and researchers say about semaglutide
Semaglutide is used for type 2 diabetes and, in particular formulations and indications, for weight management. The medicines include Ozempic, Wegovy and Rybelsus. A safety alert from the World Health Organization on 27 June 2025 relayed the European Medicines Agency’s classification of NAION as a “very rare” adverse effect.
After reviewing nonclinical studies, clinical trials, post-marketing reports and published literature, the EMA’s Pharmacovigilance Risk Assessment Committee concluded that NAION may affect up to 1 in 10,000 people taking semaglutide. In adults with type 2 diabetes, the review found an approximately two-fold increase in relative risk, corresponding to about one additional case per 10,000 person-years. A relative increase does not mean that one in every 5,000 users will develop NAION; the underlying incidence is already very low.
Evidence from observational studies is not uniform. A 2026 cohort of U.S. veterans reported 123 NAION cases per 100,000 person-years among semaglutide users versus 67 per 100,000 person-years among users of SGLT2 inhibitors. After overlap weighting, cumulative risk was 0.29% versus 0.13%, with a hazard ratio of 2.33 (95% confidence interval, 1.54–3.54) over a median 2.1 years. The participants were older, predominantly male and medically higher-risk than the general population, so the results cannot be applied directly to every semaglutide user.
Rank #2
- 【IP68 Waterproof Multifunctinal Smart Watch】Torjalph fitness activity tracker smart watch is IP68 waterproof technology ,you can wear it when swimming,handwashing,it's rain-proof which means that you perform multiple exercise modes outside without worrying about sweat or rain corroding your fitness smart watch,and this watch equipped with a 230 mAh large capacity battery magnetic charging ,and this sports activity tracker watch can be used 5-7 days If fully charged.
- 【Larger 1.83'' Full Screen Watch & Multi-dial Selection】1.83 inch full HD color touch screen smart watch for men / women provides excellent 240*284 resolution image quality ,This Bluetooth smart watch offers a better touch experience and remarkable immersion and ,more than 200 watch faces for you to choose from App"Da Fit ", you can change the dial style according to your mood to wear keeping the world on your wrist
- 【Accurate Activity Tracker Smart Watch 】sports watch activity tracker uses sweat and dust resistant breathable silicone strap, our Fitness Tracker Smart Watch for Android iOS Phones supports 12 sports modes,walking,running,bicycle,swimming,badminton,basketball,football,rope skipping. This bluetooth calls smart watch for men women is lightweight and stylish, bringing more convenient and relaxing sports experience while also providing more protection.
- 【Your 24 Hour Personal Daily Health Monitor】Fitness watch for women men full touch screen IP67 waterproof bluetooth smartwatch for Android iOS Phones with heart rate blood pressure monitor multifunction Andriod smart watch with steps counter sleep monitor sports fitness watch, monitoring blood oxygen saturation allows you to understand your physical condition in real time to track fitness progress ,to know your health status in time.
- 【More Functions Bluetooth Call Smart Watch】This fitness activity smart watch full screen for iPhone and Android phones includes a bunch of new features including:The bluetooth smart watch can hang up the phone, receive and display WhatsAPP /Text /Facebook /Twitter /Messenger reminder.Support sedentary reminder, alarm clock, stopwatch, timer,weather information,music control, remote camera control compatible with Android 5.0 and above or iOS 9.0 and above smartphones.
A review summarized by the American Academy of Ophthalmology and the North American Neuro-Ophthalmology Society (AAO/NANOS) covered more than 40 studies. Pooled analyses suggested roughly a two-fold relative-risk increase, but the evidence included a 1.2-million-patient Military Health System analysis that found no increased risk. A JAMA Ophthalmology analysis of the OHDSI network found a modest association and called for more work on mechanism and causality. Diabetes, obesity, sleep apnea, hypertension and vascular disease can each raise NAION risk, making observational results difficult to interpret.
| Evidence or estimate | What it reports | How to interpret it |
|---|---|---|
| EMA PRAC review | Very rare adverse effect; up to 1 in 10,000 users | Regulatory safety classification, not proof that semaglutide directly causes every case |
| EMA estimate in type 2 diabetes | Approximately two-fold relative-risk increase; about one additional case per 10,000 person-years | Small absolute increase against a low baseline rate |
| 2026 U.S. veteran cohort | 123 versus 67 cases per 100,000 person-years; weighted hazard ratio 2.33 (95% CI 1.54–3.54) | Observational result from an older, predominantly male, higher-risk group |
| AAO/NANOS summary | Some pooled analyses suggested about two-fold risk; another 1.2-million-person analysis found no increase | Studies are mixed and causation remains unestablished |
| Reported background incidence | 2.3–10.2 cases per 100,000 people per year | NAION is uncommon even before considering medication exposure |
Therefore, it is accurate to say that semaglutide is associated with NAION in some data and is recognized as a very rare side effect by European regulators. It is not accurate to say that semaglutide has been proven to cause NAION in an individual patient.
Symptoms that need immediate assessment
Typical NAION symptoms
- Sudden loss of vision in one eye, with or without pain.
- Sudden blurring or cloudiness, even when the loss is incomplete.
- A new missing area in the upper or lower part of the visual field.
- Rapid deterioration in eyesight over minutes or hours.
NAION is usually painless and affects one eye at first, but those features do not make it safe to wait. Sudden visual symptoms can have several causes, and only an examination can distinguish them. Do not rely on a home vision test, online symptom checker or a decision that the symptom is “just blurry vision.”
Rank #3
- [Low Noise High Fidelity] New bee guitar cord with 22AWG oxygen-free-copper center conductors provides enhanced signal transfer, the PVC insulation material and the high-density stranded copper double shield provide noise rejection for quiet operation
- [Ideal for Choice] New bee 1/4 straight and right angle metal connectors, ensures a secure connection in any instrument, pedal, or amp jack. L shape great fro on stage guitar stands
- [Wide Compatible] Suitable for mixer, power amplifier, microphone, effector, decoder, equalizer, electoronic organ, electric guitar, electric bass and other electronic equipments. Widely used in the installation of smart home, karaoke speaker, professional stage audio, etc
- [Easy Disassemble] Making incidental repairs quick and easy! Very nice, flexible cable
- [Dont Hesite to Order] 24 hours customer services and professional technology team are standing by
What to do now
- Stop what you are doing and arrange emergency care. Attend an eye-casualty service or emergency department immediately. If those services are not available locally, use the fastest emergency pathway in your region.
- Tell the receiving clinician exactly when the change began. Note which eye is affected, whether the loss is partial or complete, and whether it is worsening.
- List every medicine and condition. Include semaglutide, the formulation and dose, the date of the last dose, diabetes treatment, blood-pressure medicines and any privately obtained prescription. The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) warns that privately obtained medicines may not appear in the usual medical record.
- Request specialist ophthalmologic assessment. An eye specialist, and when appropriate a neuro-ophthalmologist, needs to examine the optic nerve and investigate other urgent causes of visual loss.
The WHO said on 27 June 2025 that people with sudden loss of vision or rapidly worsening eyesight during semaglutide treatment should contact a doctor without delay. The MHRA’s 5 February 2026 advice specifically calls for urgent ophthalmological examination when there is sudden loss, including partial loss.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Risk factors for NAION
Semaglutide exposure is only one part of the risk discussion. The following factors are identified by regulators and professional societies:
- Type 2 diabetes: Diabetes itself increases NAION risk, regardless of which glucose-lowering medicine is used.
- High blood pressure and high cholesterol: These vascular conditions can impair the blood supply relevant to the optic nerve.
- Smoking: Tobacco use adds vascular risk.
- Untreated sleep apnea: Repeated nighttime breathing interruptions and oxygen changes are associated with NAION risk.
- Overnight low blood pressure: Excessive nighttime blood-pressure lowering can reduce perfusion of the optic nerve in susceptible people.
- A very small optic-nerve cup: A crowded optic-nerve anatomy can leave less room for swelling.
- Previous NAION: The fellow eye becomes an important part of the discussion because risk is no longer limited to the eye already affected.
Some factors can be addressed, but that does not mean a person should change treatment without supervision. Discuss smoking cessation, blood-pressure timing, cholesterol management, diabetes control and evaluation for sleep apnea with the clinicians who manage those conditions. No evidence supports automatically stopping semaglutide in every person who has no visual symptoms, and AAO/NANOS do not recommend a special screening eye examination solely to look for NAION risk. People with diabetes should continue their regular diabetic eye examinations.
Rank #4
- Digital Family Calendar: BSIMB digital calendar wall touch screen puts an end to your chaotic life. Designed for busy families, the digital calendar keeps you organised and in step with your family. Assign different colours and tasks to each family member to make family scheduling easier and more intuitive.
- Easy Setup and Auto-Sync: Plug in, connect to WLAN and auto-syn your electric calendar in minutes. Digital wall calendar compatible with Google calendar, iCloud calendar, Outlook calendar, Cozi calendar and Yahoo calendar. Add events directly on the device or through the ecalendar app. Electronic calendar stays current whether you're at work or traveling—no manual updates needed.
- All-In-One Home Assistant: Smart calendar builds habits and encourage independence with personalised chores. Display daily meal plan to reduce the daily ‘What's for dinner?’ stress. To-do lists keep track of everything you want. Turning chores into valuable achievements with stars and rewards, making life easier and more enjoyable.
- Manage Anytime Anywhere: BSIMB electronic calendar for family stay connected with the powerful ecalendar app. Access and manage your digital wall calendar anytime, anywhere with free features like stars & rewards, photo screensaver, chore charts, meals plans, to-do lists etc. Electronic planner paid features like Magic Import tailor advanced tools for users with special needs.
- Stay in Touch with Loved Ones: Share photos or videos from your phone to electronic wall calendar with app, instantly update your life moment, and keep in touch with your family, especially those who are far away; you can also surprise your smart calendar digital wall by sending him a wish card; it's also great for keeping tech-illiterate elders in touch with the youngsters.
Should you stop semaglutide if your vision changes?
When NAION is confirmed
EMA and MHRA product-safety advice says semaglutide should be stopped when NAION is confirmed. That recommendation concerns a diagnosed condition, not every episode of nonspecific blur. Confirmation requires urgent clinical assessment because other eye and neurologic emergencies can look similar.
When symptoms are sudden but the diagnosis is not yet known
Seek emergency care first and bring the medication information with you. Do not delay assessment to decide whether to take the next dose, and do not restart, permanently discontinue or substitute treatment without instructions from the prescribing clinician and eye specialist. The immediate question is what is causing the vision loss.
When you have no visual symptoms but are worried
AAO/NANOS recommend discussing concerns with the clinician who prescribes semaglutide or manages your primary care. A shared decision should weigh:
- How certain the eye diagnosis is, if any diagnosis has been made.
- The very low absolute NAION rate versus the relative-risk findings.
- Your diabetes, blood-pressure, cholesterol, smoking and sleep-apnea risks.
- Your optic-nerve anatomy and any previous NAION.
- The cardiometabolic benefit you receive from semaglutide.
- Available alternative treatments and their expected benefits and risks.
- The implications for the fellow eye if NAION has already occurred.
For some patients, abruptly stopping a medicine that is controlling diabetes or providing important cardiometabolic benefit can be harmful. That is why professional societies do not endorse a blanket stop for every patient with a concern, while regulators do advise stopping after confirmed NAION.
How clinicians assess suspected NAION
The emergency examination is intended to establish whether the optic nerve is affected and to rule out other urgent causes. Tell the team the exact onset and progression, whether one or both eyes are involved, and all relevant medical and medication history. An ophthalmologist may document visual acuity, visual fields, pupil responses and the appearance of the optic disc, then order additional testing when the presentation is atypical or another diagnosis is possible.
Because NAION-related damage is often permanent and no effective vision-restoring treatment has been identified by WHO, early assessment is valuable even when the likely outcome cannot be reversed. It confirms the diagnosis, identifies risks to the other eye and allows the medication decision to be made with the correct information.
Practical prevention and follow-up conversations
Questions to take to the prescribing clinician
- What benefit is semaglutide providing for my diabetes, weight or cardiovascular risk?
- Would another treatment provide a reasonable alternative if semaglutide is stopped?
- Could my blood-pressure medicines be contributing to low overnight pressure?
- Should I be evaluated for sleep apnea or have existing apnea treatment reviewed?
- How should diabetes control be maintained if treatment changes?
Questions for the eye specialist
- Does the examination support NAION, or is another cause more likely?
- What is the risk to the fellow eye in my situation?
- Which vascular or sleep-related factors should be addressed first?
- What symptoms should trigger another emergency visit?
Do not use supplements, home remedies or self-directed dose changes as substitutes for examination. The available evidence does not establish a home treatment that reverses NAION.
Quick Recap
Key distinctions to remember
- Association is not proof of causation: Some studies report higher NAION rates with semaglutide, while others do not, and many risk factors overlap with diabetes and obesity.
- Relative and absolute risk differ: A two-fold relative increase can still represent a very small absolute risk when the baseline condition is uncommon.
- Painless does not mean harmless: Sudden, painless or partial loss is still urgent.
- Diagnosis determines the medication conversation: Confirmed NAION prompts regulator advice to stop semaglutide; uncertainty requires urgent assessment and clinician-guided shared decision-making.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
